ADGM

#4749
Adagio Medical Holdings, Inc - Common Stock
0.5 1 USD
-0.02%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
0.51
0.51
Jahresspanne
0.36
1.69
Tagesänderung
-1.92%
Monatliche Änderung
+21.43%
6 month change
-48.90%
Jahresänderung
-50.00%
Vorheriger Schlusskurs
0.5 2
Open
0.5 1
Tief
0.5 1
Hoch
0.5 1
Volumen
13
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Documents

2026

Current report, Q3 FY2026
Adagio Medical Holdings, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Adagio Medical Holdings, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Adagio Medical Holdings, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Adagio Medical Holdings, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Adagio Medical Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Adagio Medical Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Adagio Medical Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Adagio Medical Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Adagio Medical Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Adagio Medical Holdings, Inc. current report, Q2 FY2026
8-K

Adagio Medical Holdings, Inc. current report, Q2 FY2026

Full document

Adagio Medical Holdings, Inc. - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Adagio Medical Holdings, Inc. (ADGM) on April 20, 2026. The Company is an emerging growth company incorporated in Delaware and trades on The Nasdaq Stock Market LLC. The filing announces the date of the 2026 Annual Meeting of Stockholders and outlines the procedures for shareholder proposals and director nominations.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters regarding the upcoming annual meeting.

Material Changes

No material financial changes versus the prior comparable period are reported in this filing. The primary event is the scheduling of the 2026 Annual Meeting for June 16, 2026, with the record date set for April 24, 2026.

Guidance, Outlook, and Governance Procedures

  • Annual Meeting: Scheduled for June 16, 2026. Specific time and location will be disclosed in the definitive proxy statement.
  • Record Date: April 24, 2026, for determining stockholders entitled to vote.
  • Proposal Deadlines: Stockholders must submit proposals under Rule 14a-8 or director nominations under the Bylaws no later than April 30, 2026.
  • Universal Proxy Rules: Stockholders intending to solicit proxies for director nominees other than the Company's nominees must provide notice under Rule 14a-19 by April 30, 2026.
  • Submission Address: Notices must be delivered to the Company Secretary at 26051 Merit Circle, Suite 102, Laguna Hills, CA 92653.

Key Facts for Investor Verification

  • Verify the definitive proxy statement for the exact time and location of the June 16, 2026, Annual Meeting.
  • Confirm the April 30, 2026, deadline for submitting shareholder proposals or director nominations to ensure timely consideration.
  • Check the Company's Bylaws for specific information requirements that must accompany any stockholder notice.
  • Note that the Company is classified as an emerging growth company.